A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics

Clinical trial NCT02094534 · COMPLETED

Trial details

NCT number

NCT02094534

Sponsor

Oramed, Ltd.

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-03-01

Primary completion

2014-08-01

Enrollment

25

View on ClinicalTrials.gov